![]() |
|
|
Vol. 9, Issue 8, 1995-2010, August 1998
B Is a Substrate for a Selective Pathway of Lysosomal
Proteolysis



and
*Department of Physiology, Tufts University, School of Medicine,
Boston, Massachusetts 02111; and
Department of Medicine,
Harvard Institutes of Medicine, Beth Israel Deaconess Medical Center,
Boston, Massachusetts 02215
| |
ABSTRACT |
|---|
|
|
|---|
In lysosomes isolated from rat liver and spleen, a percentage of
the intracellular inhibitor of the nuclear factor
B (I
B) can be
detected in the lysosomal matrix where it is rapidly degraded. Levels
of I
B are significantly higher in a lysosomal subpopulation that is
active in the direct uptake of specific cytosolic proteins. I
B is
directly transported into isolated lysosomes in a process that requires
binding of I
B to the heat shock protein of 73 kDa (hsc73), the
cytosolic molecular chaperone involved in this pathway, and to the
lysosomal glycoprotein of 96 kDa (lgp96), the receptor protein in the
lysosomal membrane. Other substrates for this degradation pathway
competitively inhibit I
B uptake by lysosomes. Ubiquitination and
phosphorylation of I
B are not required for its targeting to
lysosomes. The lysosomal degradation of I
B is activated under conditions of nutrient deprivation. Thus, the half-life of a long-lived pool of I
B is 4.4 d in serum-supplemented Chinese hamster ovary cells but only 0.9 d in serum-deprived Chinese hamster ovary
cells. This increase in I
B degradation can be completely blocked by lysosomal inhibitors. In Chinese hamster ovary cells exhibiting an
increased activity of the hsc73-mediated lysosomal degradation pathway
due to overexpression of lamp2, the human form of lgp96, the
degradation of I
B is increased. There are both short- and long-lived
pools of I
B, and it is the long-lived pool that is subjected to the
selective lysosomal degradation pathway. In the presence of
antioxidants, the half-life of the long-lived pool of I
B is
significantly increased. Thus, the production of intracellular reactive
oxygen species during serum starvation may be one of the mechanisms
mediating I
B degradation in lysosomes. This selective pathway of
lysosomal degradation of I
B is physiologically important since
prolonged serum deprivation results in an increase in the nuclear
activity of nuclear factor
B. In addition, the response of nuclear
factor
B to several stimuli increases when this lysosomal pathway
of proteolysis is activated.
| |
INTRODUCTION |
|---|
|
|
|---|
Transcription factors are the intermediates between
receptor-mediated stimulation of the cell surface by hormones and
growth factors and concomitant changes in cellular gene expression. One of the best-characterized transcription factors is the nuclear factor
B (NF-
B),1 a heterodimeric protein
with two subunits, p50 and p65. NF-
B is ubiquitously expressed and
it regulates the expression of many genes (for review, see Baldwin,
1996
). The best-characterized role of NF-
B is in the regulation of
immune and inflammatory response genes (Verma et al., 1995
).
However, NF-
B also plays an important role in many other cellular
processes such as cell proliferation and polarization (Weith et
al., 1995
), cell transformation and tumor growth (Higgins et
al., 1993
), programmed cell death (Beg et al., 1995
),
and synaptic plasticity, neurodegeneration, and neuronal development
(O'Neill and Kaltschmidt, 1997
). In response to various stimuli that
include interleukin-1, tumor necrosis factors, bacterial and viral
products, UV irradiation, and oxidative stress, NF-
B is released
from the cytosol and translocates to the nucleus (reviewed in Baldwin,
1996
). The cytosolic retention of NF-
B requires binding to inhibitor
proteins known as inhibitor of the nuclear factor
B (I
B)
(reviewed in Verma et al., 1995
). Seven mammalian I
B
molecules have been identified which differ in their inhibitory
specificity for different members of the NF-
B family. The
best-characterized I
B is I
B
that inhibits complexes containing
p65/p50 (Scott et al., 1993
).
Under most of the conditions analyzed, degradation of I
B requires
phosphorylation and ubiquitination at its amino terminal region,
followed by proteolysis by the 26S proteasome (Alkalay et
al., 1995
; Scherer et al., 1995
). However, there are
several circumstances in which participation of other protein
degradation systems have been described. Thus, the calcium-activated
calpain system is responsible for I
B degradation after
silica-induced NF-
B activation (Chen et al., 1997
) and
for basal degradation of I
B in immature B cells (Miyamoto
et al., 1998
). Other proteolytic systems, the caspases,
which are involved in the apoptotic process, can also be involved in
I
B degradation in certain transformed cells (White and Gilmore,
1996
), and an unphosphorylated form of I
B
is degraded in the
nucleus by an unknown proteinase which is not sensitive to proteasome
inhibitors (Suyang et al., 1996
). In addition, in pre-B
cells degradation of I
B does not require phosphorylation and
ubiquitination steps (Baeuerle and Baltimore, 1996
). An I
B QL-rich
region seems to be important in inducible degradation of I
B by the
proteasome (Sun et al., 1996
). Signal sequences for protein
instability (PEST sequences) identified in the I
B carboxyl-terminal
region have been proposed to be important for I
B degradation in
unstimulated cells (van Antwerp and Verma, 1996
) without participation
of the 26S proteasome. These findings suggest that degradation of I
B
can be by different pathways depending on the type of cell and the kind
of stimulus applied.
In preliminary experiments in which a lysosomal membrane protein (Adra
et al., 1996
) was overexpressed in several cell lines, we
found an activation and nuclear translocation of NF-
B (Hu and Lim,
unpublished results). This led us to question whether lysosomes may be
involved in I
B degradation. In the present study, we have
investigated the possible participation of lysosomes in I
B
degradation under different cellular conditions. In addition to the
continuous lysosomal degradation of complete portions of cytosol,
including organelles and soluble proteins, by a mechanism known as
macroautophagy (Dunn, 1994
), a selective degradation of cytosolic
proteins in lysosomes has also been described (reviewed in Dice
et al., 1990
; Cuervo et al., 1997
).
Transport of specific cytosolic proteins into lysosomes requires the
presence of a consensus peptide motif in the substrate protein
biochemically related to the pentapeptide KFERQ (Chiang and Dice,
1988
). A cytosolic chaperone of 73 kDa (hsc73) binds to the substrate
proteins at the region containing the motif sequence, and this binding
of hsc73 stimulates the direct transport of substrate proteins into
lysosomes (Chiang et al., 1989
; Terlecky et al.,
1992
). A second chaperone located within the lysosomal lumen (lysosomal
hsc73) is also necessary for the selective uptake of substrate proteins
(Agarraberes et al., 1997
; Cuervo et al.,
1997
). An integral lysosomal membrane protein of 96 kDa (lgp96)
acts as the receptor for the hsc73-mediated lysosomal degradation
pathway (Cuervo and Dice, 1996
). This selective lysosomal degradation
is activated in conditions of serum deprivation in cultured cells (Neff
et al., 1981
) or long-term starvation in animals (Wing
et al., 1991
; Cuervo et al., 1995a
), and shows a
clear tissue-dependent activity (Wing et al., 1991
).
Approximately 30% of the total cytosolic proteins contain the
KFERQ-related motif and are, therefore, putative substrates for this
lysosomal pathway of degradation (Dice, 1990
). The proteins
experimentally identified as substrates include RNase A (Neff et
al., 1981
; McElligott et al., 1985
), GAPDH (Aniento
et al., 1993
), aldolase (Aniento et al., 1993
),
components of other proteolytic systems such as some subunits of the
20S proteasome (Cuervo et al., 1995b
), lipid-binding proteins such as annexins II, IV, and VI (Cuervo, Barnes, and Dice,
unpublished results), a cytosolic form of
2-microglobulin (Cuervo, Hildebrand, Bomhard, and
Dice, unpublished results), and the c-fos transcription factor (Aniento
et al., 1996
).
Here, we show that I
B is directly transported into lysosomes by the
above-described hsc73-mediated pathway. This pathway of proteolysis can
reduce intracellular levels of I
B and cause activation of NF-
B.
Furthermore, when this selective lysosomal pathway of proteolysis is
activated, the activity of NF-
B is more easily stimulated by diverse
agents.
| |
MATERIALS AND METHODS |
|---|
|
|
|---|
Animals and Cells
Male Wistar rats of 200-250 g body weight were starved for
20 h before each experiment. Chinese hamster ovary (CHO) cells (American Type Culture Collection, Rockville, MD) were grown in 100-mm
diameter round plates or 250 mm per side square plates until confluent
in F-12 medium (Life Technologies, Gaithersburg, MD) containing 10%
newborn calf serum (NCS) and antibiotics (penicillin/streptomycin) (Neff et al., 1981
). WEHI231 cells lines stably transfected
with and expressing a hemagglutinin (HA; amino acid 98-108 of the
influenza protein) epitope-tagged SS32/36AA mutant I
B
were kindly
provided by Dr. S. Miyamoto (Department of Human Oncology, University
of Wisconsin, Madison, WI). These cells were maintained in RPMI 1640 (Mediatech, Asheville, NC) supplemented with 10% FBS, 5 × 10
5 M
-mercaptoethanol, and 500 µg/ml hygromycin. To
deprive cells of serum, plates were extensively washed with HBSS (Life
Technologies), and fresh medium not containing serum was added.
Chemicals and Antibodies
Sources of reagents and antibodies were as previously described
(Terlecky and Dice, 1993
; Cuervo et al., 1994
; Adra et
al., 1996
; Cuervo et al., 1997
). IL-1
(IL-1)
was purchased from Oncogene (Cambridge, MA). Lipopolysaccharide (LPS),
tumor necrosis factor
(TNF-
), phorbol 12-myristate 13-acetate
(PMA), and pyrrolidine dithiocarbamate (PDTC) were purchased from Sigma
(St. Louis, MO). The calf intestinal alkaline phosphatase was from Life
Technologies. Polyclonal antibodies against I
B
and
, p65 and
p50, were obtained from Santa Cruz Biotechnology (Santa Cruz, CA), and
the mAb against conjugated ubiquitin was purchased from Zymed (South
San Francisco, CA). The mAb (12CA5) against the amino acids 98-108 of
the HA protein was from Dr. F. McKeon (Department of Cell Biology,
Harvard Medical School, Boston, MA). The polyclonal antibody against
the cytosolic region of lgp96 was prepared in our laboratory (Cuervo and Dice, 1996
). The polyclonal antibody against the nuclear factor of
activated T cells 1 was a gift from Dr. A. Rao (Department of
Pathology, Harvard Medical School, Boston, MA). The plasmid containing
the fusion protein GST-I
B
was kindly provided by Dr. S. Ghosh
(Department of Molecular Biophysics and Biochemistry, Yale University,
New Haven, CT).
Stable Cellular Transfection
Cells were transfected using the calcium phosphate method
(Maniatis et al., 1982
). The cDNA for human lamp2 (Fukuda
et al., 1988
) was subcloned in the pCR3 mammalian expression
vector (Invitrogen, San Diego, CA). Selection of transfected cells was
performed by resistance to Geneticin (400 µg/ml; Life Technologies)
for at least 15 d. Individual colonies were grown in 48-well
plates in the presence of the antibiotic for another 7 d.
Expression of the protein was verified by immunofluorescence of fixed
cells and immunoblot of cellular lysates after separation
by SDS-PAGE.
Isolation of Subcellular Fractions
Spleen and liver from previously starved rats were homogenized
in 0.25 M sucrose. Subcellular fractions were prepared by differential centrifugation and further centrifugation in a density gradient of
metrizamide as described previously (Cuervo et al.,
1995
; Adra et al., 1996
). Lysosomal matrix and
membranes were obtained as described previously (Ohsumi et
al., 1983
). Briefly, lysosomes were pelleted and resuspended in a
hypotonic solution (0.025 M sucrose) for 30 min at 0°C. Lysosomal
membranes were sedimented by centrifugation at 105,000 × g for 30 min, and the supernatant corresponding to the
lysosomal matrix was also separately recovered. In some experiments,
two different groups of lysosomes with different contents of hsc73 were
isolated as previously described (Cuervo et al.,
1997
). Lysosomes from cultured cells were isolated as described
by Storrie and Madden (1990)
. In all of the experiments, lysosomal
integrity was verified after isolation and at the end of the incubation
period by measuring the activity of
-hexosaminidase, a lysosomal
enzyme, in the incubation medium (Storrie and Madden, 1990
).
Experiments with more than 10% broken lysosomes were discarded.
Proteolysis Measurements
Degradation of the I
B already located in the lysosomal matrix
was measured by incubation of intact lysosomes (50 µg of protein) in
10 mM MOPS/0.25 M sucrose/5 mM DTT (pH 7.2) at 37°C. At selected times aliquots were removed, separated by SDS-PAGE, and the remaining I
B inside lysosomes was detected by immunoblot.
Lysosomal degradation of exogenously added proteins was assayed by
incubation of intact lysosomes in the above medium with GAPDH
radiolabeled by reductive methylation (Jentoft and Dearborn, 1983
)
([14C]GAPDH; 1.2 × 106 dpm/nmol), a
pool of cytosolic proteins from human fibroblasts, or GST-I
B
metabolically labeled with [3H]leucine or
[35S]methionine/cysteine, respectively
([3H]proteins, 2.0 × 106 dpm/µg;
[35S]GST-I
B, 7.3 × 106 dpm/nmol).
Reactions were stopped with a final concentration of 10%
trichloroacetic acid and, after filtration in the Millipore Multiscreen
Assay System (Millipore, Bedford, MA) with a 0.45-µm pore membrane,
radioactivity in the flow-through was measured in a 2100TR Packard
liquid scintillation analyzer (Packard Instruments, Meriden, CT).
Proteolysis was expressed as the percentage of the initial
acid-precipitable radioactivity transformed to acid-soluble radioactivity during the incubation time.
Uptake of Proteins by Lysosomes
Transport of proteins into isolated lysosomes was analyzed using
a previously described in vitro system (Terlecky and Dice, 1993
; Cuervo
et al., 1994
). Briefly, lysosomal proteolytic activity was
inhibited by treatment of freshly isolated lysosomes with 100 µM
chymostatin for 10 min at 0°C. After dilution in two volumes of 10 mM
MOPS/0.25 M sucrose (pH 7.2) buffer, lysosomes were incubated with
GST-I
B (5 µg) for 20 min at 37°C. At the end of the incubation, the protein remaining outside lysosomes was removed by treatment with
proteinase K (3 µg) at 0°C for 10 min. Lysosomes were recovered by
centrifugation and subjected to SDS-PAGE. GST-I
B transported into
lysosomes was detected by immunoblot after SDS-PAGE. Where indicated GST-I
B was previously incubated with calf intestinal alkaline phosphatase (40 U) in 50 mM Tris-HCl/0.1 mM EDTA/0.3 M
NaCl/0.1 mM MgCl2/10 µM ZnCl2 (pH 8.5) for
1 h at 37°C.
Determination of I
B Half-Life
CHO cells at 60-70% confluency were radiolabeled with an
[35S]methionine/cysteine mixture (0.2 mCi/ml) for 48 h in medium supplemented with 10% NCS. In some experiments the
incubation lasted only 2 h to preferentially label short-lived
proteins. After extensive washing, cells were maintained in the
presence of 10% NCS (serum+) or in medium without serum (serum
).
Where indicated, NH4Cl was added to a final concentration
of 15 mM. In some experiments PDTC or H2O2 was
added at the indicated concentrations in the fresh medium immediately
after the labeling. At increasing times cells were lysed in lysis
buffer [50 mM Tris-HCl (pH 8)/150 mM NaCl/1% Nonidet-P40/0.5% sodium
deoxycholate/0.1% SDS]. Lysates were cleared by centrifugation, and
supernatants were incubated with specific antibodies against I
B or
p65 previously conjugated to protein A-Sepharose beads. After extensive
washing with lysis buffer, the immunoprecipitate was subjected to
SDS-PAGE. Gels were exposed to a PhosphorImager screen and the
immunoprecipitated I
B or p65 was quantified with a PhosphorImager
system (Molecular Dynamics, Sunnyvale, CA). The half-life of the
protein was calculated from the formula t1/2 = ln2/degradation rate.
Electromobility Gel Shift Assay
Nuclear extracts from CHO cells were prepared as follows. Cells
(1.5 × 107) were grown until confluent in medium
supplemented with 10% NCS and then, after extensive washing, the
medium was replaced with fresh medium with or without serum as
indicated. After 16 h (except where indicated) cells were
harvested, washed, and resuspended in hypotonic buffer [10 mM Tris-HCl
(pH 7.4)/10 mM NaCl/30 mM MgCl2/0.02% sodium azide] with
a broad range of proteinase inhibitors (0.1 mM
4-(2-aminoethyl)-benzenesulfonyl fluoride, 100 µM leupeptin, 1 µM
pepstatin A, 1 mM EDTA, and 0.01% sodium azide). After 10 min at
0°C, 0.05% of Nonidet P-40 was added, and nuclei were pelleted by
centrifugation at 2500 × g for 5 min. Pellets were
washed with the same buffer and resuspended in 20 mM HEPES (pH 7.4)/420
mM NaCl/1.5 mM MgCl2/0.2 mM EDTA/25% glycerol/0.01%
sodium azide with proteinase inhibitors for 30 min. After
centrifugation at 12,000 × g for 10 min, nuclear
proteins were recovered in the supernatant and stored at
70°C. A
double-stranded oligonucleotide containing the immunoglobulin
enhancer kB site of NF-
B (CAGAGGGGACTTTCCGAGA) was end labeled with
T4 polynucleotide kinase in the presence of 20 µCi of
[
-32P]ATP. Binding assays were performed by incubation
of nuclear proteins (5 µg) with the radiolabeled probe (10,000 dpm)
and 0.5 µg of poly(dI-dT) in 8.5 mM HEPES (pH 7)/ 104 mM NaCl/0.2 mM
DTT/8.5% glycerol for 20 min at 25°C. Samples were subjected to
electrophoresis in a 4% nondenaturing polyacrylamide gel. After
drying, the gel was exposed to a PhosphorImager screen. In some
experiments, nuclear transport of NF-
B was induced by addition of
PMA, LPS, IL-1, TNF-
, or H2O2 at the
indicated concentrations in the culture medium 4 h prior to cell
harvesting. The specificity of the binding to NF-
B in the nuclear
extracts was determined by competition in the presence of a 200-fold
excess of unlabeled oligonucleotide probe.
General Methods
SDS-PAGE (Laemmli, 1970
), immunoblotting (Towbin
et al., 1979
), and fluorography (Bonner and Laskey, 1974
)
were performed by standard procedures. Protein concentration in samples
was measured according to the Lowry et al. (1951)
method
using BSA as a standard. Hsc73 was purified from rat liver by affinity
chromatography using an ATP-agarose matrix (Welch and Feramisco, 1985
).
GST-I
B was isolated from Escherichia coli previously
transformed with the above-mentioned vector and after induction with 1 mM isopropyl-
-D-thiogalactopyranoside for 4 h (Maniatis et al., 1982
). The GST-I
B was purified with a
glutathione-agarose column. Densitometric analyses were performed with
an Image Analyzer System (Inotech S-100, Sunnyvale, CA).
| |
RESULTS |
|---|
|
|
|---|
Immunolocalization of I
B in Lysosomes
As a first step toward determining whether lysosomes were involved
in the intracellular degradation of I
B, we analyzed whether or not
I
B could be detected in the lysosomal fraction. As shown in Figure
1, A and B, most of the intracellular
I
B
and
is located in the cytosol. Both proteins also
associate to some extent with microsomes but are not detected in
mitochondria. In lysosomes it is possible to detect I
B
and
which account for 1.5% and 1.0% of the I
B in spleen homogenate,
respectively, when corrected for lysosomal recovery. A portion of the
lysosome-associated I
B (30-42%) is located at the lysosomal
membrane, probably bound to its cytosolic surface, but the remaining
I
B is within the lysosomal matrix. Only slight differences were
found in the lysosomal content of I
B
and
. The presence of
I
B in lysosomes is not the result of a cytosolic contamination in
the process of isolation since the mitochondrial fraction, obtained by
similar methods, does not show detectable levels of I
B. In addition,
no detectable levels of two other transcriptional factors (p65 of
NF-
B and NFAT-1) were evident in the lysosomes (Figure 1, C and D).
|
Lysosomal Degradation of I
B
The lysosome-associated I
B can be readily degraded once inside
the lysosomal matrix. Thus, when liver lysosomes were incubated in an
isotonic medium to maintain lysosomal integrity and levels of I
B
associated with lysosomes were analyzed by immunoblot
(Figure 2A), the lysosomal content of
I
B decreased with the incubation time, and this decrease was slowed
in the presence of leupeptin, an inhibitor of cathepsin B, H, and L
(Salvelsen and Nagase, 1989
). Quantification of four
immunoblots similar to the ones shown revealed that the
half-life of I
B
and
once inside lysosomes was approximately 20 min. Since I
B
and
behaved similarly in these initial
studies, we chose to analyze further only I
B
.
|
To estimate degradation rates of I
B that could be attributed to
lysosomes in vivo, we compared lysosomal levels of this protein in
control rats and in rats previously treated with leupeptin for 1 h
to partially inhibit the lysosomal proteolytic activity. As shown in
Figure 2B, after leupeptin treatment, there is a significant increase
in lysosome-associated I
B (52% more than in untreated animals), and
this increase is mainly detected in the lysosomal matrix. On the basis
of these results and the above-mentioned half-life of I
B once inside
the lysosomal matrix, we calculated that in starved rats approximately
0.4% of the total intracellular content of I
B is transported into
lysosomes per hour. Notice that the final value has been corrected for
the percentage of lysosomal recovery in the isolation.
Pathway for Lysosomal Uptake of I
B
The significant differences between the lysosomal amount of I
B
and that of other transcription factors could be related to their
different proteolytic susceptibility once inside lysosomes. However,
experiments with broken lysosomes revealed that half-lives of I
B and
NF-
B were similar once in contact with the lysosomal proteinases
(approximately 15 min; our unpublished results). These results suggest
that the transport of I
B into lysosomes is selective and preferred
over other cytosolic proteins. To determine whether I
B could be
entering lysosomes through the hsc73-mediated pathway, we isolated two
lysosomal populations with very different activities for the
hsc73-mediated transport (Cuervo et al., 1997a
). The
major difference between these groups of lysosomes is their different content of hsc73, a necessary factor for substrate protein uptake (Agarraberes et al., 1997
; Cuervo et al., 1997a
;
Figure 3, top). As shown in Figure 3
(middle), levels of I
B in the lysosomal population active in the
direct transport pathway were significantly higher than in the less
active population. As a control, levels of hexokinase, a cytosolic
protein that has been reported to not follow the selective pathway for
its transport to lysosomes (Cuervo et al., 1997a
), were
similar in both groups (Figure 3, bottom). These results suggest that
I
B might be a substrate for the selective lysosomal pathway of
protein degradation.
|
We used isolated lysosomes to analyze a possible direct uptake of I
B
(Terlecky and Dice, 1993
; Cuervo et al., 1994
). Lysosomes from rat spleen (Figure 4A, right) or
liver (Figure 4A, left) were incubated with the radiolabeled fusion
protein GST-I
B to differentiate it by size from the I
B already
present in the lysosomal matrix. When lysosomes were sedimented after
the incubation, part of GST-I
B was associated with lysosomes. Some
of this protein was resistant to proteinase treatment and therefore was
located in the lysosomal matrix. These results suggest that GST-I
B
can be transported in vitro into lysosomes.
|
These transport experiments were performed without addition of
exogenous hsc73, because we have previously demonstrated that the
levels of hsc73 associated with the membrane of rat liver lysosomes are
sufficient to mediate the transport of substrate proteins into the
lysosomal matrix (Cuervo et al., 1994
). In addition, when
35S-labeled I
B was incubated with intact lysosomes from
CHO cells with low levels of membrane-associated hsc73, a clear
dependence on hsc73 and ATP for the uptake and degradation of I
B was
observed (see below).
To determine whether the transport system used by I
B was the
hsc73-mediated pathway previously described, or at least whether I
B
shared some of the components of this system for its transport into
lysosomes, we analyzed the effect of different substrates (RNase A,
GAPDH) and nonsubstrate proteins (ovalbumin) on the I
B lysosomal
uptake. After incubation, all samples were treated with proteinase K to
detect the amount of protein transported into the lysosomal matrix. As
shown in Figure 4B, in the presence of two of the substrates for the
hsc73-mediated transport, the amount of I
B transported into
lysosomes significantly decreased. However, addition of ovalbumin in
the incubation medium did not modify I
B uptake. In addition, when
lgp96, the receptor protein at the surface of the lysosomes for the
specific substrates was previously blocked with a specific antibody, a
decrease in the uptake of I
B was also observed. Incubation of
lysosomes with a preimmune serum did not significantly modify levels of
I
B uptake (Figure 4C).
Finally, another characteristic of the cytosolic proteins that can be
directly transported into lysosomes is their ability to bind to hsc73,
a molecular chaperone. This binding is nucleotide dependent because ADP
is required for substrate binding and ATP is necessary for substrate
release. A consensus motif for binding to hsc73 has been previously
identified in substrates for this pathway (Dice, 1990
). Analysis of the
I
B sequence revealed the presence of a region biochemically related
with the proposed pentapeptide (VKELQ amino acids 46-50). When
GST-I
B was incubated with hsc73 and the fusion protein was recovered
by affinity binding to GST-agarose beads, part of the hsc73 was also
recovered (Figure 4D). Levels of hsc73 recovered in the presence of ATP
were significantly lower. Most hsc73 bound directly to the GST-I
B,
since in the absence of GST-I
B hsc73 was hardly detected (Figure 4D,
lane 4). No binding of hsc73 occurred to GST itself (our unpublished
results). This interaction of I
B with hsc73 was also detected in
vivo. Using a specific antibody against I
B, we were able to
coimmunoprecipitate hsc73 from cytosolic extracts of CHO cells (Figure
4E, lane 3). Interestingly, after serum removal cytosolic levels of
hsc73 remain constant (Figure 4E, lane 2) but the amount of hsc73
coprecipitated with I
B was significantly higher (12-fold increase;
Figure 4E, lane 4). As shown in Figure 4E, lanes 7 and 8, the amount of
NF-
B coprecipitated with I
B remained unchanged at this early
point of serum deprivation. In isolated rat liver lysosomes not only hsc73 (Figure 4F, lane 2) but also lgp96 (Figure 4F, lane 4) was coimmunoprecipitated with I
B. These results together suggest that,
at least in vitro, the direct transport of I
B through the lysosomal
membrane requires most of the components of the hsc73-mediated system.
To determine whether the lysosomal degradation of I
B in living cells
is mediated by the selective lysosomal pathway, we analyzed the effect
that an increase in the activity of this pathway has on I
B uptake
and degradation. We have previously demonstrated that an increase in
the lysosomal levels of lgp96 results in an increased activity of the
pathway (Cuervo and Dice, 1996
). As shown in Figure
5A, lysosomes from CHO cells
stably overexpressing lgp96 (twofold increase) show a significant
increase in the uptake and degradation of GAPDH but not of a pool of
cytosolic proteins, most of which are not substrates for this lysosomal
pathway of proteolysis. Uptake and degradation of I
B by those
lysosomes was also increased (Figure 5A). Differences in degradation
rates for I
B among those groups of lysosomes were mainly due to
differences in the protein transported, since endogenous levels of
I
B in lysosomes from transfected cells were significantly higher
than in lysosomes from untransfected cells (Figure 5B). Lysosomal
levels of hexokinase, a nonsubstrate for the hsc73-mediated pathway, were similar in the two groups analyzed.
|
Role of Ubiquitination and Phosphorylation of I
B in Its
hsc73-mediated Transport into Lysosomes
As described above, I
B undergoes phosphorylation and
polyubiquitination under specific conditions, and polyubiquitination targets the proteins for degradation by the 26S proteasome complex. The
presence of polyubiquitinated proteins bound to the lysosomal membrane
and inside the lysosomal matrix has been reported previously (Lenk
et al., 1992
). To determine whether covalent binding of ubiquitin to I
B was also necessary for its lysosomal uptake, we
separately immunoprecipitated the I
B in the lysosomal matrix and
membrane. Using an antiubiquitin antibody, we further analyzed by
immunoblot for the presence of ubiquitin in the I
B
immunoprecipitates. As shown in Figure
6A, this antibody recognized high
molecular weight ubiquitinated complexes in cytosol and in lysosomal
membranes and matrix not subjected to immunoprecipitation (lanes 1-3),
but none of those high molecular weight complexes were detected in the
I
B immunoprecipitated from lysosomal membrane and matrix (lanes 5 and 6). Covalent binding of a single molecule of ubiquitin to I
B is
also not necessary for its lysosomal uptake because the
immunoprecipitated I
B was not recognized by the specific antibody
against ubiquitin (lanes 5 and 6). Thus, ubiquitination seems to be
unnecessary for the selective transport of I
B to lysosomes because
the I
B located in the lysosomal matrix or associated with the
lysosomal membrane is not ubiquitinated.
|
Phosphorylation of I
B at serines 32 and 36 is required for its
signal-induced degradation by the 26S proteasome (Alkalay et
al., 1995
; Scherer et al., 1995
). To determine whether
phosphorylation of those residues is also required for the lysosomal
degradation of I
B, we analyzed the lysosomal content of I
B in
WEHI231 cells stably transfected with a HA epitope-tagged S32/36A I
B
mutant. As shown in Figure 6B, the mutated I
B can be detected inside lysosomes using a specific antibody against the HA tag (Figure 6B, lane
2). Levels of endogenous and mutated I
B inside lysosomes correlate
with their levels in the total homogenate, suggesting that both forms
of I
B are equally transported inside lysosomes (Figure 6B, lanes 3 and 4). Phosphorylation of I
B on other residues also appeared not to
be necessary for its lysosomal transport. When the fusion protein
GST-I
B used to analyze direct transport of I
B into isolated
lysosomes was pretreated with a phosphatase, we found no significant
differences in the rates of I
B binding or uptake by lysosomes
(Figure 6C, compare lanes 5 and 6 and lanes 7 and 8).
Physiological Relevance of I
B Degradation by the hsc73-mediated
Lysosomal Pathway
The hsc73-mediated lysosomal pathway is activated during serum
deprivation in cultured cells or prolonged starvation in animals. To
analyze the participation of lysosomes in I
B degradation, we
compared the I
B half-life in CHO cells in the presence or absence of
serum and the effect of NH4Cl, a lysosomal inhibitor (Figure 7). Rates of degradation of I
B
were measured by radioactive labeling of CHO cells followed by
immunoprecipitation of I
B at different times. As shown in Figure 7A
(top), we found a significant increase in I
B degradation when serum
was removed from the culture medium. No change in NF-
B degradation
under conditions of serum deprivation were found (Figure 7A, bottom).
In addition, when lysosomal degradation was partially inhibited by
NH4Cl, a marked decrease in I
B degradation was observed
in the absence of serum (Figure 7B, left). Changes in I
B degradation
during serum removal are even more dramatic in cells overexpressing
lamp2 when compared with normal cells (approximately 1.8 times faster)
(Figure 7B, right). After determining I
B degradation rates in three
independent experiments similar to the ones described above (Figure
7C), we calculated that the half-life of intracellular I
B in the
presence of serum is 4.4 d and in the absence of serum is 0.9 d. When NH4Cl was added, the half-lives obtained were 3.0 and 3.3 d in the presence and absence of serum, respectively. No
changes were detected in the degradation rates of NF-
B in the
absence of serum when NH4Cl was added (our unpublished
results). These results show that I
B is more rapidly degraded during
serum deprivation, a condition known to activate the hsc73-mediated
selective lysosomal pathway. Furthermore, during serum deprivation,
lysosomes are the major site for this accelerated degradation because
treatment with NH4Cl results in more than 90% inhibition
of the serum-regulated I
B degradation.
|
We also analyzed the degradation of I
B after 2 h of
radiolabeling to determine whether I
B was degraded with single
exponential kinetics or whether two different degradation patterns
could be detected in CHO cells. After the short labeling, most of the
radiolabeled I
B was degraded in the first 40 min both in the absence
and in presence of serum (Figure 8A).
However, after long exposure of the fluorographies containing the
immunoprecipitates, it was possible to detect a portion of I
B that
was slowly degraded in cells supplemented with serum (Figure 8B). That
portion of I
B was also detected in cells deprived of serum but its
degradation was markedly faster (Figure 8B). When I
B proteolytic
rates were analyzed in three separate experiments, we observed a pool
of I
B with a very short-half life (39 and 25 min in the presence and
in absence of serum, respectively) along with a second pool of I
B
with a half-life of 3 d or more. As shown in Figure 8A, during the
first hour of chase the degradation of I
B was slightly faster in the
absence of serum than in the presence of serum, but differences in
degradation were markedly higher during 6-30 h of chase (Figure 8B).
The detectable serum-dependent increase in I
B degradation in the
first hour of chase was not altered by NH4Cl (our
unpublished results), suggesting that this increase is not due to
lysosomal proteolysis. Thus, only the degradation rates of the
long-lived pool significantly increased in response to serum
deprivation and only under those conditions was I
B degradation inhibited by NH4Cl (Figure 7C).
|
Finally, we analyzed the effect of the increase in lysosomal I
B
degradation on NF-
B activity using electrophoretic mobility shift
assays with a radiolabeled probe containing the immunoglobulin
enhancer NF-
B-binding site. In nuclear extracts from CHO cells, this
probe bound to a high molecular weight complex identified with specific
antibodies (our unpublished results) as the p65/p50 heterodimer of the
NF-
B family (as labeled in Figure 9).
In many of the nuclear preparations, the probe also specifically bound to a lower molecular weight complex identified as the p50/p50 homodimer
of the NF-
B family. However, since this complex was not always
detected, all of the quantification of data refer to the p65/p50
heterodimer. First of all, we observed a constitutive activation of
NF-
B in CHO cells. When serum was removed for 16 h, there were
no detectable changes in NF-
B activation. If anything, the levels of
nuclear NF-
B were slightly decreased. However, nuclear levels of
NF-
B in serum-supplemented cells overexpressing lamp2 were 3.5 times the levels in nontransfected cells (Figure 9A). Moreover, when
serum was removed for 16 h, the difference between transfected and
nontransfected cells was even higher (nuclear NF-
B was 5.6 times
more in cells overexpressing lamp2). Transfection of cells with an
empty expression vector did not modify nuclear levels of NF-
B. No
significant differences in NF-
B activation in the presence or the
absence of serum under those conditions were found for nontransfected
cells. However, in nontransfected cells, when serum deprivation was
prolonged to more than 2 d (Figure 9B, top panel), we detected a
significant increase in NF-
B activation. This increase in NF-
B
nuclear activity correlated well with a decrease in the cytosolic
levels of I
B in serum-deprived cells (Figure 9B, bottom panel).
Interestingly, the pattern of NF-
B activation by prolonged serum
deprivation showed certain cell-type specificity. For example, in human
fibroblasts there was a rise and fall in nuclear NF-
B corresponding
with a decrease and increase in levels of I
B (Figure 9C, bottom
panel). The serum-induced increase in nuclear NF-
B activity also
started earlier but it lasted for a shorter time than in CHO cells
(Figure 9C, top panel).
|
We have previously described that the hsc73-mediated lysosomal pathway
of protein degradation is already active in CHO cells after 16 h
of serum deprivation, and its activity progressively increases with the
starvation time (Cuervo and Dice, 1996
). As we have shown before
(Figure 7), it is possible to detect a significant increase in the
degradation of intracellular I
B after 12 h of serum
deprivation, but we found increased NF-
B activity only after 2 d or more of starvation (Figure 9, B and C). However, the initial
increased degradation of I
B after serum removal clearly has an
effect on the sensitivity of the NF-
B activation in response to
several activating agents. Thus, in CHO cells deprived of serum for
only 12 h, we were able to detect a consistent increase in the
NF-
B response to PMA, LPS, IL-1, and TNF-
when compared with
serum-supplemented cells (Figure 10).
|
Targeting of I
B to Lysosomes for Its Degradation
The exact mechanism that triggers I
B and other substrates of
the hsc73-mediated pathway for its degradation in lysosomes remains
unclear. It is known that the NF-
B response can be inhibited by
antioxidants (Baeuerle and Henker, 1994
) that somehow suppress a
reaction required for release of I
B from NF-
B (Schreck et al., 1992
). In addition, certain oxidized proteins are better substrates for the hsc73-mediated pathway (Cuervo and Knecht, unpublished results). To determine a possible role of reactive oxygen
species in the lysosomal targeting of I
B, we further analyzed the
effect of PDTC, a known antioxidant, in the degradation of the
long-lived pool of I
B. As shown in Figure
11A, PDTC was able to inhibit the
NF-
B response to agents such as IL-1 and
H2O2 not only in the presence but also in the
absence of serum in CHO cells. In the presence of PDTC, there is a
decrease in the degradation rates of I
B after serum removal, and
this inhibitory effect in the I
B degradation is proportional to the
amount of PDTC added (Figure 11B, lanes 4-6). The fact that the
addition of H2O2 to the incubation medium under
conditions of serum deprivation markedly increase I
B degradation
(Figure 11C) also suggests the participation of reactive oxygen species
in the targeting of I
B to lysosomes in response to serum withdrawal.
|
| |
DISCUSSION |
|---|
|
|
|---|
The inducible degradation of I
B bound to NF-
B by the 26S
proteasome is a well-characterized process that results in activation of NF-
B (van Antwerp and Verma, 1996
). Although other proteolytic systems have been implicated in I
B degradation under specific circumstances (see INTRODUCTION), there have been no published studies
implicating lysosomes in I
B degradation. In this work, we have
identified in cultured cells a long-lived pool of I
B that is more
rapidly degraded in response to serum deprivation (Figure 7). This
finding may explain why serum deprivation can activate NF-
B in
several cell types in culture (Grimm et al., 1996
; Figures 9
and 10).
The long-lived pool of I
B might allow cells to increase NF-
B
activity more slowly than by the proteasome pathway. In fact, NF-
B
activity increases only after 2 d of serum deprivation (Figure 9).
The long-lived pool of I
B may consist of conformational variants or
heteromeric assemblies that have buried signals for
ubiquitination. Under conditions of serum deprivation, this long-lived
I
B might be modified to expose the putative KFERQ motif, leading to
binding by hsc73 and to transport into lysosomes. Ubiquitination or
phosphorylation of I
B is not required for this lysosomal uptake
(Figure 6).
The stimuli that determine I
B interaction with hsc73 and its
subsequent degradation by this selective lysosomal pathway remain unclear. It has been previously described that the heat shock response
inhibits I
B degradation (Wong et al., 1997
); however, the
hsc73 involved in the lysosomal transport is not the heat shock
inducible form but its constitutively expressed family member. The
trigger for I
B recognition by hsc73 might be located in the I
B
molecule itself. Our studies with the antioxidant agent PDTC (Figure
11) indicate that oxidation of I
B might play an important role in
its lysosomal targeting under conditions of serum deprivation.
The lysosomal population isolated from rat liver has been previously
well characterized and it mainly corresponds to primary lysosomes
derived from hepatocytes with undetectable levels of autophagic
vacuoles or multivesicular bodies (Aniento et al., 1993
;
Cuervo et al., 1994
). Compared with liver, spleen has a very
heterogenous cellular composition. However, the method that we used to
isolate lysosomes allows separation of lysosomes that are mainly
derived from lymphocytes (Bowers, 1974
). In addition, lysosomes
isolated from a lymphocyte cell line in culture (Jurkat cells) also
contain I
B (our unpublished results). The recovery of lysosomes from
rat spleen was approximately 4%, a slightly lower value than from rat
liver (5.5%; Cuervo et al., 1995a
). The purity of
both lysosomal preparations, determined by assaying activity of
mitochondrial and cytosolic marker enzymes as possible contaminants,
was very high (>99%).
The percentage of total intracellular I
B detected in lysosomes from
spleen (Figure 1) is only 1.0-1.5% of the total in homogenates. However, this value corresponds to a steady-state condition of import
and degradation inside the lysosomal matrix. As shown in Figure 2,
using rat liver lysosomes, once I
B reaches the lysosomal matrix, it
is rapidly degraded. This conclusion is also supported by the effect of
leupeptin, a lysosomal inhibitor, on levels of lysosomal I
B (Figure
2B). In those experiments, we found that approximately 0.4% of the
total I
B in liver was degraded in lysosomes per hour (see RESULTS,
Lysosomal Degradation of I
B). Based on that degradation rate and by
applying the formula t1/2= ln2/degradation rate,
we calculated that the half-life of I
B due to lysosomal degradation
is approximately 7 d. However, only 40% inhibition of lysosomal
degradation has been reported after leupeptin injection into rats
(discussed in Cuervo et al., 1995b
). Therefore, the half-life of the I
B that can be attributed to lysosomal proteolysis would be closer to the value of 4 d experimentally determined in
CHO cells (Figure 7).
Several of the results presented here strongly implicate I
B as a
substrate for the hsc73-mediated pathway of lysosomal proteolysis: 1)
the higher I
B content in lysosomes active in the direct uptake of
proteins (Figure 3); 2) the direct interaction of I
B with the
cytosolic hsc73 (Figure 4D) and with lgp96, the receptor at the
lysosomal membrane (Figure 4C); 3) the direct transport in vitro of
I
B into isolated rat liver and CHO cell lysosomes (Figures 4A and
5A); 4) the ATP/hsc73 dependence of this transport (Figure 5A); 5) the
competitive effect of other substrates of the hsc73-mediated pathway on
I
B lysosomal uptake (Figure 4B); 6) the serum-dependent activation
of I
B lysosomal degradation in cultured cells (Figure 7); and 7) the
increase in I
B lysosomal degradation in cells with an increased
activity for the hsc73-mediated lysosomal pathway (Figures 5 and 7B).
It is likely that only free forms of I
B are directly transported
into lysosomes, since no NF-
B was detected inside lysosomes. Whether
or not the free I
B has been previously bound to NF-
B or whether
it corresponds to a pool of newly synthesized free I
B remains
unclear. Previous studies reported a half-life for free I
B of
approximately 30 min (van Antwerp and Verman, 1996
). However,
degradation of overexpressed I
B in cultured cells was analyzed
instead of the endogenous I
B, and the radioactive labeling was
performed for only 1 h. When we performed a short labeling of CHO
cells for 2 h, instead of our initial 2 d, we also found a
very fast NH4Cl-insensitive degradation of I
B during the
first hour of the chase period (Figure 8). This short labeling period strongly favors labeling of rapidly turning over proteins. Thus, only
by prolonging the labeling time can the slowly turning over I
B be
labeled and therefore clearly detected after immunoprecipitation.
The inhibitory effect of NH4Cl on the degradation of I
B
in the absence of serum revealed that, under those conditions, >90% of the intracellular I
B is degraded by lysosomes. In contrast with
chloroquine, another common lysosomal inhibitor, NH4Cl, at the concentrations used in this study, does not interfere with I
B
synthesis (Chen et al., 1997
). The absence of an effect of lysosomal inhibition on I
B half-life in other studies (Verma et al., 1995
) can be explained by analysis of degradation
being performed only in the presence of serum. Under such conditions we
also found little effect of NH4Cl (Figure 7C).
There is a constitutive activation of NF-
B in CHO cells (Figure 9A).
We have also observed constitutive NF-
B activation in other cell
lines such as HL-60 hematopoietic cells and human fibroblasts. We have
found a consistent slight decrease in the NF-
B activity during the
first 12 h of serum deprivation. The decrease in many regulatory
factors present in serum could in some manner cause that initial
decrease in NF-
B activity. Then the NF-
B activity clearly
increases with increases in the activity of the lysosomal pathway, such
as in CHO cells overexpressing lamp 2 (Figure 9A), or after prolonged
serum removal (Figure 9B). The differences in the kinetics of
activation of NF-
B between CHO cells and human fibroblasts (Figure
9) might be explained by the difference in the activity of the
hsc73-mediated pathway in the two cell types. We have previously
described that the activity of this pathway is significantly higher in
human fibroblasts than in CHO cells (Cuervo and Dice, 1996
). The faster
decrease in the cytosolic levels of I
B in human fibroblasts by a
higher rate of lysosomal degradation can explain the more rapid
increase in NF-
B activity in these cells. This increase in NF-
B
activity can also more quickly induce the expression of
I
B, an NF-
B responsive gene, and thereby
limiting the duration of the NF-
B response (Sun et al.,
1993
). Among normal hematopoietic lineages, B cells are the only cell
type in which there is a constitutive activation of NF-
B. In these
cells, an enhanced degradation of the pool of rapidly turning over
I
B was found to be the main reason for the activation of NF-
B
without external stimuli (Miyamoto et al., 1994
;
Verma et al., 1995
). The response of NF-
B to serum deprivation has been previously reported in cultured cells (Grimm et al., 1996
), and we have demonstrated that this
serum-regulated activation of NF-
B correlates with the activation of
the selective lysosomal degradation of I
B (Figure 9, B and C).
In addition to the regulation of the constitutive activity of NF-
B
after prolonged starvation, the selective lysosomal degradation of
I
B also contributes to the modulation of stimuli-mediated activation
of NF-
B. Although there is no significant difference in the levels
of total I
B between normal CHO cells versus those deprived of serum
for 12 h (our unpublished results), it is possible that the
serum-starved cells contain a reduced level of the long-lived pool of
I
B. This would explain the increased NF-
B activation in response
to the different stimulatory agents in those cells (Figure 10). The
amount of long-lived I
B compared with short-lived I
B seems to
depend on the cell type. In unstimulated lymphoid cells the long-lived
pool of I
B can also be detected, but it constitutes a lower
percentage (18%) of the total I
B than in CHO cells (our unpublished
results). It has been suggested that an excess of I
B
in
unstimulated cells would prevent rapid inducibility and reduce the
sensitivity of the NF-
B system (Baeuerle and Henker, 1994
). In
contrast, a reduction in levels of I
B would increase the sensitivity
of the NF-
B system. The selective degradation of I
B in lysosomes,
for example, under conditions of stress and starvation, appears to be
one of the operative mechanisms.
Together, our data show that the long-lived pool of I
B can influence
the sensitivity of the NF-
B system and that this may be modulated by
a selective lysosomal proteolytic pathway. The sensitivity of the
selective lysosomal degradation of I
B to stress such as serum
starvation indicates that this regulatory pathway has a physiological
role. Thus, our findings support the proposal that the I
B protein
has evolved multiple mechanisms of degradation (van Antwerp and Verma,
1996
). The lysosomal degradation of I
B described in this article
offers a new mechanism of control of the NF-
B function through
modifications of the activity of the hsc73-mediated lysosomal pathway.
| |
ACKNOWLEDGMENTS |
|---|
We thank Dr. Fernando Macian for his expert advice and technical
assistance in the electromobility gel shift assays of NF-
B. We also
thank Elizabeth Frutiger for the critical reading of the manuscript.
Special thanks to Dr. S. Ghosh for the GST-I
B
plasmid and Dr. S. Miyamoto for the WEHI231 cell lines expressing SS32/36AA I
B
mutant protein. This work was supported by National Institutes of
Health grant DK-07542 (to A.M.C.), National Institutes of Health grant
AG-06116 (to J.F.D.), National Institutes of Health grant DK-47636, and
Council for Tobacco Research grant 4488 (to B.L.). B.L. is also a
Scholar of the Leukemia Society of America.
| |
FOOTNOTES |
|---|
Corresponding authors: Department of
Physiology, Tufts University, School of Medicine, 136 Harrison Avenue,
Boston, MA 02111 (A.M.C). E-mail: acuervo{at}opal.tufts.edu. Department
of Medicine, Beth Israel Deaconess Medical Center, Harvard Institutes
of Medicine, Boston, MA 02215 (B.L.). E-mail:
blim{at}bidmc.harvard.edu.
| |
ABBREVIATIONS |
|---|
Abbreviations used:
CHO, Chinese hamster ovary;
HA, hemagglutinin;
I
B, inhibitor of the nuclear factor
B;
LPS, lipopolysaccharide;
NCS, newborn calf serum;
NF-
B, nuclear factor
B;
PDTC, pyrrolidine dithiocarbamate;
PMA, phorbol 12-myristate 13-acetate;
TNF-
, tumor necrosis factor
.
| |
REFERENCES |
|---|
|
|
|---|
B
phosphorylation marks the NF-
B inhibitor for degradation via the ubiquitin-proteasome pathway.
Proc. Natl. Acad. Sci. USA
92, 10599-10603
B in the immune system.
Annu. Rev. Immunol.
12, 141-179[Medline].
B.
Nature
376, 167-170[Medline].
B-alpha degradation and nuclear factor-
B activation.
Arch. Biochem. Biophys.
342, 383-388[Medline].
B induced upon apoptosis.
J. Cell Biol.
134, 13-23
B blocks tumorigenicity and causes tumor regression.
Proc. Natl. Acad. Sci. USA
90, 9901-9905
B
proteolytic pathway in WEHI231 immature B cells.
Mol. Cell. Biol.
18, 19-29
Ba requires site-specific ubiquitination.
Proc. Natl. Acad. Sci. USA
92, 11259-11263
B activation in intact cells.
J. Exp. Med.
175, 1181-1194
B regulates I
B by two distinct mechanisms.
Genes Dev.
7, 1266-1276
B
regulate its inducible degradation.
Mol. Cell. Biol.
16, 1058-1065
B controls expression of inhibitor I
B
: evidence for an inducible autoregulatory pathway.
Science
259, 1912-1915
B
in persistent activation of NF-
B.
Mol. Cell. Biol.
16, 5444-5449
B
: association with NF-
B and the PEST sequence in I
B
are not required.
Mol. Cell. Biol.
16, 6037-6045
B/I
B family: intimate tales of association and dissociation.
Genes Dev.
9, 2723-2735
B/Rel family.
Cell
80, 331-340[Medline].This article has been cited by other articles:
![]() |
Y. Wang, M. Martinez-Vicente, U. Kruger, S. Kaushik, E. Wong, E.-M. Mandelkow, A. M. Cuervo, and E. Mandelkow Tau fragmentation, aggregation and clearance: the dual role of lysosomal processing Hum. Mol. Genet., November 1, 2009; 18(21): 4153 - 4170. [Abstract] [Full Text] [PDF] |
||||
![]() |
T. Copetti, C. Bertoli, E. Dalla, F. Demarchi, and C. Schneider p65/RelA Modulates BECN1 Transcription and Autophagy Mol. Cell. Biol., May 15, 2009; 29(10): 2594 - 2608. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Garate, E. I. Campos, J. A. Bush, H. Xiao, and G. Li Phosphorylation of the tumor suppressor p33ING1b at Ser-126 influences its protein stability and proliferation of melanoma cells FASEB J, November 1, 2007; 21(13): 3705 - 3716. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. Petersen Shay, Z. Wang, P.-x. Xing, I. F.C. McKenzie, and N. S. Magnuson Pim-1 Kinase Stability Is Regulated by Heat Shock Proteins and the Ubiquitin-Proteasome Pathway Mol. Cancer Res., March 1, 2005; 3(3): 170 - 181. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Lee, Y.-S. Kim, D.-H. Choi, M. S. Bang, T. R. Han, T. H. Joh, and S.-Y. Kim Transglutaminase 2 Induces Nuclear Factor-{kappa}B Activation via a Novel Pathway in BV-2 Microglia J. Biol. Chem., December 17, 2004; 279(51): 53725 - 53735. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Deng, P. D. Lu, Y. Zhang, D. Scheuner, R. J. Kaufman, N. Sonenberg, H. P. Harding, and D. Ron Translational Repression Mediates Activation of Nuclear Factor Kappa B by Phosphorylated Translation Initiation Factor 2 Mol. Cell. Biol., December 1, 2004; 24(23): 10161 - 10168. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Kiffin, C. Christian, E. Knecht, and A. M. Cuervo Activation of Chaperone-mediated Autophagy during Oxidative Stress Mol. Biol. Cell, November 1, 2004; 15(11): 4829 - 4840. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. O'Connor, S. D. Shumway, I. J. Amanna, C. E. Hayes, and S. Miyamoto Regulation of Constitutive p50/c-Rel Activity via Proteasome Inhibitor-Resistant I{kappa}B{alpha} Degradation in B Cells Mol. Cell. Biol., June 1, 2004; 24(11): 4895 - 4908. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Yang, S. M. Bernier, T. E. Ichim, M. Li, X. Xia, D. Zhou, X. Huang, G. H. Strejan, D. J. White, R. Zhong, et al. LF15-0195 generates tolerogenic dendritic cells by suppression of NF-{kappa}B signaling through inhibition of IKK activity J. Leukoc. Biol., September 1, 2003; 74(3): 438 - 447. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. De Bosscher, W. Vanden Berghe, and G. Haegeman The Interplay between the Glucocorticoid Receptor and Nuclear Factor-{kappa}B or Activator Protein-1: Molecular Mechanisms for Gene Repression Endocr. Rev., August 1, 2003; 24(4): 488 - 522. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. S. Russell and P. J. Tofilon Radiation-induced Activation of Nuclear Factor-kappa B Involves Selective Degradation of Plasma Membrane-associated Ikappa Balpha Mol. Biol. Cell, October 1, 2002; 13(10): 3431 - 3440. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. Uchinami, Y. Yamamoto, M. Kume, K. Yonezawa, Y. Ishikawa, K. Taura, A. Nakajima, K. Hata, and Y. Yamaoka Effect of heat shock preconditioning on NF-kappa B/I-kappa B pathway during I/R injury of the rat liver Am J Physiol Gastrointest Liver Physiol, June 1, 2002; 282(6): G962 - G971. [Abstract] [Full Text] [PDF] |
||||
![]() |
I. Leclerc, C. Lenzner, L. Gourdon, S. Vaulont, A. Kahn, and B. Viollet Hepatocyte Nuclear Factor-4{alpha} Involved in Type 1 Maturity-Onset Diabetes of the Young Is a Novel Target of AMP-Activated Protein Kinase Diabetes, July 1, 2001; 50(7): 1515 - 1521. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Frossard, C. M. Pastor, and A. Hadengue Effect of hyperthermia on NF-{kappa}B binding activity in cerulein-induced acute pancreatitis Am J Physiol Gastrointest Liver Physiol, June 1, 2001; 280(6): G1157 - G1162. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Mizrahi and C. Moore Posttranslational Phosphorylation and Ubiquitination of the Saccharomyces cerevisiae Poly(A) Polymerase at the S/G2 Stage of the Cell Cycle Mol. Cell. Biol., April 15, 2000; 20(8): 2794 - 2802. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Montagnoli, F. Fiore, E. Eytan, A. C. Carrano, G. F. Draetta, A. Hershko, and M. Pagano Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation Genes & Dev., May 1, 1999; 13(9): 1181 - 1189. [Abstract] [Full Text] |
||||
![]() |
D. J. Kouba, H. Nakano, T. Nishiyama, J. Kang, J. Uitto, and A. Mauviel Tumor Necrosis Factor-alpha Induces Distinctive NF-kappa B Signaling within Human Dermal Fibroblasts J. Biol. Chem., February 23, 2001; 276(9): 6214 - 6224. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. M. Cuervo, A. V. Gomes, J. A. Barnes, and J. F. Dice Selective Degradation of Annexins by Chaperone-mediated Autophagy J. Biol. Chem., October 20, 2000; 275(43): 33329 - 33335. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Moriwaki, N. A. Begum, M. Kobayashi, M. Matsumoto, K. Toyoshima, and T. Seya Mycobacterium bovis Bacillus Calmette-Guerin and Its Cell Wall Complex Induce a Novel Lysosomal Membrane Protein, SIMPLE, That Bridges the Missing Link between Lipopolysaccharide and p53-inducible Gene, LITAF(PIG7), and Estrogen-inducible Gene, EET-1 J. Biol. Chem., June 15, 2001; 276(25): 23065 - 23076. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. A. Franch, S. Sooparb, J. Du, and N. S. Brown A Mechanism Regulating Proteolysis of Specific Proteins during Renal Tubular Cell Growth J. Biol. Chem., May 25, 2001; 276(22): 19126 - 19131. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||